The target of 8.7 is a very realistic target, considering the bird flu play and the up coming HIV play too, and last but not least, no share placement to dilute the share price.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential